$Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients$
QR Code

Final Phase IIa Study Results Evaluating the CXCR4 Antagonist BL-8040 in Combination with Cytarabine (Ara-C) for the Treatment of Relapsed/Refractory AML Patients

Saved in:

Bibliographic Details
Published in:	Clinical lymphoma, myeloma and leukemia Vol. 16; p. S28
Main Authors:	Borthakur, Gautam, Tallman, Martin, Ofran, Yishai, Foran, James, Uy, Geoffrey, DiPersio, John, Nagler, Arnon, Rowe, Jacob, Showel, Margaret, Altman, Jessica, Peled, Amnon, Abraham, Michal, Pereg, Yaron, Vainstein, Abi, Oberkovitz, Galia, Lustig, Tzipi, Aharon, Arnon, Bueso-Ramos, Carlos, Cortes, Jorge, Andreeff, Michael
Format:	Journal Article
Language:	English
Published:	Elsevier Inc 01-09-2016
Subjects:	Hematology, Oncology and Palliative Medicine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	2152-2650 2152-2669
DOI:	10.1016/j.clml.2016.07.040